Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rotigotine for early morning motor impairment in Parkinson's disease
NCT00243945Phase 3Completed
- Sponsor
- UCB
- Start
- Dec 2004
- Primary completion
- Jul 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of rotigotine in Parkinson's disease (PD), sponsored by UCB. Started Dec 2004; status: completed.
02
Drugs
rotigotine
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT00243945.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00243945.